WORKSHOP LOGISTICS WORKSHOP REGISTRATION IMPORTANT REMINDERS  
empty2006 Joint Meeting
empty

PRELIMINARY AGENDA

Plenary Speakers

Stefano Bertozzi, M.D., Ph.D., Instituto Nacional de Salud Pública, Cuernavaca, Mexico

Ross Prentice, Ph.D., Professor, Biostatistics, Fred Hutchison Cancer Research Center, University of Washington - Seattle

 

Session I (Chair: Dr. Steve Self)

  • Modeling at the community level
    • Defining models for the dynamics of infectious agents propagated within sexual networks and the integration of these models into study design and statistical inference
    • Estimation of population and individual effects in community-based vaccine studies
    • The role of biological cofactors in HIV spread: Modeling the HIV and malaria interaction

  • Genetic/genomic analysis in HIV research
    • Methodology of variable selection and estimation with high dimensional data
    • Mapping human genetic determinants of susceptibility and response to HIV infection
    • Impact of phylogenetic relationships on the assessment of genetic associations
    • Viral population estimation using pyrosequencing

Session II (Chair: Dr. Victor DeGruttola) 

  • Causal inference methods as applied to statistical problems in AIDS research
    • Relating HIV viral genotype to in-vitro phenotypic and clinical responses to treatment in an observational setting
    • Statistical learning of realistic individualized treatment rules from observational data
    • Determining clinical strategies for switching treatment of HIV-infected patients on non-suppressive therapy

  • Treatment strategies and evaluation of surrogate outcomes methodology
    • Development of methods for estimating optimal treatment strategy from observational and randomized trial data
    • Evaluation of surrogates using a potential outcomes framework, with application to immunological surrogate endpoints in a vaccine efficacy trial

Poster Session

  • Abstracts submitted by workshop participants

Session III (Chair: Dr. Stephen Gange)   

  • Pooling data from observational studies and clinical trials
    • Risk prediction models
    • Heterogeneity across datasets/studies
  • Communicating epidemiologic research
    • Using epidemiology data to inform policy
    • Standards in epidemiology research and reporting

Session IV: (Moderators TBD)

DHHSNIAIDNIHlogo